Main > A1. CORP. INDEX. S-Sm > Samsung Bioepis Co. Ltd./P C2
Samsung Bioepis Co. Ltd./P C2's subsections
2015. 12.04. Rheuma.>RA>Infliximab
2016. 09.12. Rheuma.>AS & RA
2017. 04.24. Rheuma.>RA>Infliximab
2017. 08.20. Takeda Pharma
2017. 11.20. Onco.>TrastuzuMAb
2018. 10.17. AdalimuMAb EU Launch
2019. 01.21. Onco.>TrastuzuMAb
2019. 04.29. FDA Approves
2019. 07.24. FDA Approves
2019. 09.10. Rheuma.>AS & RA BR
2020. 04.15. Onco.>TrastuzuMAb
web-site
Samsung Bioepis Co. Ltd./P C2's products
This section has no products